Regulation of T- and B-cell interactions determines the clinical phenotype associated with donor-specific antibodies

Kidney Int. 2022 May;101(5):877-879. doi: 10.1016/j.kint.2022.02.020.

Abstract

The cellular mechanisms that regulate donor-specific antibody formation and antibody-mediated rejection remain unknown. In this issue, Louis et al. report that specific T-regulatory cell and B-regulatory transitional cell subsets are concomitantly diminished in patients with donor-specific antibody and consequent antibody-mediated rejection and advance alterations in specific cytokines and costimulatory molecules as important mechanisms by which these cells may suppress donor-specific antibody formation and, independently, progression to antibody-mediated rejection.

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antibodies
  • Cell Communication
  • Graft Rejection* / prevention & control
  • Humans
  • Kidney Transplantation*
  • Phenotype
  • Tissue Donors

Substances

  • Antibodies